ObsEva SA (OBSEF)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 6, 2026
0.00%
Market Cap 11.72K
Revenue (ttm) 19.64M
Net Income (ttm) 7.92M
Shares Out 117.18M
EPS (ttm) 0.07
PE Ratio 0.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 19,140
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range n/a
Beta 13.56
RSI 51.03
Earnings Date n/a

About ObsEva

ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 15
Stock Exchange OTCMKTS
Ticker Symbol OBSEF
Full Company Profile

Financial Performance

In 2022, ObsEva's revenue was $19.64 million, a decrease of -11.55% compared to the previous year's $22.20 million. Losses were -$29.88 million, -43.60% less than in 2021.

Financial Statements

News

There is no news available yet.